RAYMOND DEBBANE
CIK 1053890 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$506.30M
Companies
7
Total Filings
124
Lifetime Open-Market Net
-$72.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | Director | 3,533,960 | $1.92 | $6.79M | $5.43M | 35 | 2026-06-04 |
| SRRK | 10%+ Owner | 11,051,166 | $44.18 | $488.24M | -$78.79M | 1 | 2024-11-27 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 7,146,381 | $15.70 | $112.20M | -$355.5K | 1 | 2024-08-05 |
| WW | Director | 134,387 | $18.55 | $2.49M | $320.1K | 18 | 2023-05-11 |
| WTW | Director | 33,426 | $262.63 | $8.78M | $1.00M | 62 | 2019-04-03 |
| BUFF | Director | 0 | $52.31 | $0 | $0 | 3 | 2018-04-24 |
| Ceres, Inc. (CERE) Delisted | Director | — | $44.96 | — | $0 | 3 | 2014-03-11 |
Recent Filings · Page 11 of 13
124 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-10-06 | WTW | Grant (A) | +298 | $0 | EDGAR |
| 2010-07-07 | WTW | Grant (A) | +366 | $0 | EDGAR |
| 2010-05-03 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2010-04-07 | WTW | Grant (A) | +365 | $0 | EDGAR |
| 2010-01-06 | WTW | Grant (A) | +321 | $0 | EDGAR |
| 2009-12-15 | WTW | Grant (A) | +1,000 | $0 | EDGAR |
| 2009-10-06 | WTW | Grant (A) | +346 | $0 | EDGAR |
| 2009-07-07 | WTW | Grant (A) | +366 | $0 | EDGAR |
| 2009-04-28 | — | Disp (D) | −19,956,096 | -$17.13M | |
| 2009-04-27 | LXRX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.